Related Experiment Video
Updated: May 6, 2026

Field Identification of Matricaria chamomilla using a Portable qPCR System
Published on: October 10, 2020
A correction of misinformation regarding Herbalife
Kristy Appelhans1, Raushanah Najeeullah, Vasilios Frankos
1Kristy Appelhans, Raushanah Najeeullah, Vasilios Frankos, Department of Global Product Science Safety and Compliance, Herbalife International of America Inc, Torrance, CA 90502, United States.
Abstract:
The authors of the subject article by Senadhi et al have misrepresented the safety and regulatory status of Herbalife's products. While we are very concerned with the unwarranted and unfavorable publicity that the inaccuracies listed could generate for Herbalife, we would welcome any inquiries that these authors may have to better clarify our commitment to the safety and quality of our products as has been demonstrated in part by our ability to establish positive relationships with regulatory authorities worldwide through continued cooperation and compliance. This letter clarifies the misinformation presented about Herbalife in the subject article.
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Confirmation Biases
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Healing I: Introduction
Plant Hormones
Antihypertensive Drugs: Thiazide-Class Diuretics

